Shipeng Ning

2.0k total citations · 2 hit papers
67 papers, 1.4k citations indexed

About

Shipeng Ning is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Shipeng Ning has authored 67 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Biomedical Engineering, 27 papers in Molecular Biology and 27 papers in Materials Chemistry. Recurrent topics in Shipeng Ning's work include Nanoplatforms for cancer theranostics (49 papers), Advanced Nanomaterials in Catalysis (20 papers) and Nanoparticle-Based Drug Delivery (9 papers). Shipeng Ning is often cited by papers focused on Nanoplatforms for cancer theranostics (49 papers), Advanced Nanomaterials in Catalysis (20 papers) and Nanoparticle-Based Drug Delivery (9 papers). Shipeng Ning collaborates with scholars based in China, Hong Kong and Singapore. Shipeng Ning's co-authors include Meng Lyu, Shouping Xu, Daoming Zhu, Tianfu Zhang, Jacky W. Y. Lam, Da Pang, Ben Zhong Tang, Qinqin Huang, Qin Wang and Pan You and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Shipeng Ning

60 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge

2023 207 citations Shipeng Ning, Meng Lyu et al. ACS Nano profile →
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer

2025 30 citations Shipeng Ning, Ping Shangguan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shipeng Ning China	21	673	643	386	362	202	67	1.4k
Wenmin Cao China	19	458 0.7×	522 0.8×	295 0.8×	234 0.6×	314 1.6×	35	1.3k
Dong Cen China	14	492 0.7×	524 0.8×	310 0.8×	246 0.7×	105 0.5×	37	1.1k
Naishun Liao China	25	656 1.0×	473 0.7×	167 0.4×	310 0.9×	197 1.0×	53	1.4k
Fangfang Chen China	15	335 0.5×	520 0.8×	168 0.4×	204 0.6×	234 1.2×	44	1.2k
Kaixin Liao China	7	506 0.8×	362 0.6×	169 0.4×	291 0.8×	279 1.4×	11	1.0k
Ali Talebi Belgium	9	328 0.5×	961 1.5×	758 2.0×	289 0.8×	250 1.2×	16	1.8k
Weimin Yin China	16	499 0.7×	357 0.6×	124 0.3×	197 0.5×	136 0.7×	33	1.0k
Ligang Xia China	16	396 0.6×	528 0.8×	331 0.9×	187 0.5×	188 0.9×	37	955
Jian Deng China	13	732 1.1×	408 0.6×	251 0.7×	284 0.8×	493 2.4×	16	1.2k
Lihua Du China	16	426 0.6×	514 0.8×	136 0.4×	217 0.6×	176 0.9×	28	1.1k

Countries citing papers authored by Shipeng Ning

Since Specialization

Citations

This map shows the geographic impact of Shipeng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shipeng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shipeng Ning more than expected).

Fields of papers citing papers by Shipeng Ning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shipeng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shipeng Ning. The network helps show where Shipeng Ning may publish in the future.

Co-authorship network of co-authors of Shipeng Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Shipeng Ning. A scholar is included among the top collaborators of Shipeng Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shipeng Ning. Shipeng Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ning, Shipeng, et al.. (2026). T lymphocyte membrane bionic nanomedicine synergizes with radiotherapy for enhancing Mg ²⁺ -mediated tumor metallo-immunotherapy and preventing recurrence. Theranostics. 16(7). 3634–3647.

Ning, Shipeng, Xia Wang, Xiaoyuan Fan, et al.. (2025). Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy. Science Advances. 11(36). eadr8001–eadr8001.

Zou, Donghua, Zhaoshi Bao, Chun Zou, et al.. (2025). Precise Diffusion of Gaseous H ₂ S “Bomb” Potentiates NIR‐II Imaging‐Guided Photothermal Therapy by Relieving Heat Tolerance and Disturbing Cellular Homeostasis for Synergistic Orthotopic Glioblastoma Treatment. Advanced Functional Materials. 35(46). 2 indexed citations

Xu, Qingyong, Minmin Zhang, Song Gao, et al.. (2025). Organic AIE Nanoradiosensitizer Potentiates X‐Ray Triggered Continuous Reactive Oxygen Species Generation for Potent Cancer Radioimmunotherapy. Advanced Materials. 37(35). e2502898–e2502898. 5 indexed citations

Zhang, Minmin, et al.. (2025). Bionic gene nanomedicines for targeted enhancement of cuproptosis-mediated tumor immunotherapy. Chemical Engineering Journal. 518. 164489–164489. 2 indexed citations

Zhang, Zeyuan, et al.. (2024). Breaking through therapeutic barriers: Insights into CDK4/6 inhibition resistance in hormone receptor-positive metastatic breast cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(5). 189174–189174. 3 indexed citations

Wang, Xia, Shipeng Ning, Wenhui Tao, et al.. (2024). Cytomembrane-targeted photodynamic priming triggers extracellular vesicle storm for deep penetration and complete destruction of bladder cancer. Nano Today. 56. 102311–102311. 10 indexed citations

Chen, Zhongxian, Zeming Liu, Jiaxin Lin, et al.. (2024). Bionic aggregation-induced emission photosensitizer for enhanced cancer immunotherapy. Materials Today Bio. 28. 101217–101217. 17 indexed citations

Yang, Jing, Florencia G. Que, Lin Huang, et al.. (2024). A Turbo‐Charging System‐Like Contrast Agent for MRI‐Guided STING Pathway‐Activated Cancer Immunotherapy. Advanced Science. 12(1). e2410432–e2410432. 2 indexed citations

10.

Li, Lei, Hongbin Wang, Song Gao, et al.. (2024). Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer. International Journal of Surgery. 110(8). 4716–4726. 9 indexed citations

11.

Wang, Wenqi, Jie Shan, Junyao Zhu, et al.. (2024). MnGA with multiple enzyme-like properties for acute wound healing by reducing oxidative stress and modulating signaling pathways. Materials Today Bio. 30. 101435–101435. 2 indexed citations

12.

Zhang, Tianfu, Meng Suo, Pan You, et al.. (2024). Stimuli-Responsive Hydrogels Potentiating Photothermal Therapy against Cancer Stem Cell–Induced Breast Cancer Metastasis. ACS Nano. 18(31). 20313–20323. 19 indexed citations

13.

Suo, Meng, Hanchen Shen, Meng Lyu, et al.. (2024). Biomimetic Nano‐Cancer Stem Cell Scavenger for Inhibition of Breast Cancer Recurrence and Metastasis after FLASH‐Radiotherapy. Small. 20(29). e2400666–e2400666. 24 indexed citations

14.

Hu, Yixiang, et al.. (2024). Emerging roles of ferroptosis in pulmonary fibrosis: current perspectives, opportunities and challenges. Cell Death Discovery. 10(1). 301–301. 20 indexed citations

15.

Liu, Jinyuan, et al.. (2024). Enhancing tumor endothelial permeability using MUC18-targeted gold nanorods and mild hyperthermia. Journal of Colloid and Interface Science. 676. 101–109. 11 indexed citations

16.

Chen, Tianyou, Shipeng Ning, Xinli Zhan, et al.. (2024). Exploring T Cell and NK Cell Involvement in Ankylosing Spondylitis Through Single‐Cell Sequencing. Journal of Cellular and Molecular Medicine. 28(24). e70206–e70206. 2 indexed citations

17.

Ning, Shipeng, Meng Lyu, Daoming Zhu, et al.. (2023). Type-I AIE Photosensitizer Loaded Biomimetic System Boosting Cuproptosis to Inhibit Breast Cancer Metastasis and Rechallenge. ACS Nano. 17(11). 10206–10217. 207 indexed citations breakdown →

18.

Ning, Shipeng, Meng Suo, Qinghua Huang, et al.. (2023). Biomimetic fusion liposomes boosting antitumor immunity and promote memory T cell differentiation to inhibit postoperative recurrence of breast cancer. Nano Today. 54. 102106–102106. 24 indexed citations

19.

Zhang, Tianfu, Pan You, Meng Suo, et al.. (2023). Photothermal‐Triggered Sulfur Oxide Gas Therapy Augments Type I Photodynamic Therapy for Potentiating Cancer Stem Cell Ablation and Inhibiting Radioresistant Tumor Recurrence. Advanced Science. 10(29). e2304042–e2304042. 42 indexed citations

20.

Li, Hui, Hao Wu, Qin Wang, et al.. (2021). Dual effects of N6-methyladenosine on cancer progression and immunotherapy. Molecular Therapy — Nucleic Acids. 24. 25–39. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact